
Latest Insights on IMMU

February 4, 2020 American Investor Today, Stocks
Abbvie’s flagship medication Humira is a huge seller in the U.S. and abroad. But as more companies develop their own versions, will Abbvie’s stock crater in the face of tighter competition? I’ll review Abbvie’s balance sheet and fundamentals to let you know whether you should expect the stock to surge — or fall even further in 2020.
January 31, 2020 American Investor Today, Diversified Investments
The coronavirus is spreading fear through global markets. But there is one beaten-down sector that will emerge from the global crisis even stronger. Anthony Planas reveals the No. 1 fund that every investor should add to their portfolio today.
January 16, 2020 Bold Profits Daily, Investment Opportunities, Technology
Precision medicine just took a massive leap forward. This mega medical trend in personalized health care offers investors huge profit potential.
December 12, 2019 Investment Opportunities, Technology, Winning Investor Daily
Biotech stocks are naturally speculative. You don’t want to use your lunch money to buy them. But they can deliver life-changing gains.
December 5, 2019 Great Stuff
The Right Prescription for Massive Returns Today, dear readers, we’re going to cover a topic I just know you all love and adore: biotechnology. I can hear the groans already … and I get it. All those big scary words that have no real meaning to you at all. It’s like they’re talking about some […]